NFKB1 and Hepatitis: SP effectively suppressed IKK, IκB, and p65 phosphorylation, modulated the NF-κB signaling pathway, downregulated IL-1β, IL-6, and TNF-α expression, and mitigated EtOH-induced liver inflammation.